RheumaGen Inc
RheumaGen Inc. is a cell and gene therapy company focused on developing innovative therapeutics for major autoimmune diseases by editing the human leukocyte antigen (HLA). Its lead program, RG0401, aims to provide a one-time, curative treatment for treatment-resistant or refractory rheumatoid arthritis (RA).
Leadership & Board
- Current Number of Employees
- 6
- Current LinkedIn Followers
- 1,102
Latest Estimated Valuation
- Estimated Valuation
- ―
- Total Amount Raised
- $15M
- Total Funding Rounds
- 1
- Latest Funding Amount
- $15M
- Latest Funding Round
- Series A
- Post-Money Valuation
- ―
Company Momentum Positive
RheumaGen Inc LinkedIn following is increasing, signaling rising market interest, while its workforce is growing, indicating business expansion.
Employee Trend
RheumaGen Inc had 6 employees as of October 12, 2026. The number of employees increased by 0 (0.00%) week-over-week.
Social Trend
RheumaGen Inc had 1,102 followers as of October 12, 2026. The number of followers increased by 11 (1.01%) week-over-week.
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Jan 09, 2025 | Series A | $15.00M | ― |
Investors
| Investor Name | Funding Round |
|---|---|
| SPRIM Global Investments | Series A |
| William Taylor Nominees | Series A |
Similar Companies
A snapshot of private companies similar to RheumaGen Inc, helping you discover and navigate related company profiles.
